Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
ACHFF
Primary Symbol:
V.ARCH
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok...
). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
williepoker
X
View Profile
View Bullboard History
Post by
williepoker
on Dec 22, 2021 10:47am
Pumped & Dumped
Pump and dump
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Dec 22, 2021 10:30am
RE:RE:PFOF?
So >65% of the float is insider + F/F owned, and that group keeps adding shares. We've all told our collective friends, family and anybody who would listen to buy, so I suspect the group of
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Dec 22, 2021 9:52am
RE:PFOF?
Had good volume yesterday, but there was only one good bid. Need bids in the stack to turn the Algos the other direction. With only the market maker in the stack the Algos do what they want.
...more
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Dec 22, 2021 9:45am
PFOF?
I regularly see posts like '10k shares available to $5' on CEO and sometimes here. If that were the case, why wouldn't someone with a 200k+ share position just buy 10k shares at market
...more
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Comment by
Riverfolk
on Dec 20, 2021 10:04pm
RE:New to this board
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Dec 20, 2021 9:32pm
Arch Shareholders
This stock is my largest holding, I have been on this board for 4 years while i have accumilated stock. My posts below indicate my thoughts, I dont need to react to swings in the price on this board
...more
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Dec 20, 2021 8:38pm
MetaBlok - A Pathway to an unmet 20 billion market
This past week Arch Biopartners released a glimpse of the human data waiting on publication from a third party, that should be expected shortly. This data was further validated by CATCO when they
...more
(17)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Dec 20, 2021 8:34pm
Arch Biopartners - My Due Diligence (NEW)
Arch Biopartners Inc. is a clinical stage company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch is
...more
(1)
•••
fourbarrels
X
View Profile
View Bullboard History
Comment by
fourbarrels
on Dec 20, 2021 2:14pm
RE:RE:RE:RE:Nobody else seems concerned AT ALL
CEO.CA | #arch Arch Biopartners Inc. (ARCH.V) Alive and well over at CEO
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Dec 20, 2021 1:26pm
RE:RE:RE:Nobody else seems concerned AT ALL
Interesting about Riverfolk. Hadn't connected the dots there. Nowhere to be seen now.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Dec 20, 2021 1:11pm
RE:RE:Nobody else seems concerned AT ALL
Agree. Volume low so any selling is going to bring prce down. There is no interest in selling. We already had the day when lots of shares were dumped. Riverfolk pumped this stock hard and now
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Dec 20, 2021 12:26pm
RE:Nobody else seems concerned AT ALL
I know several that are going to be buying big, why pay $4 when you can get 3.50, not many sellers left though!
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Dec 20, 2021 11:59am
Nobody else seems concerned AT ALL
Feels like I'm taking crazy pills here.
(1)
•••
fourbarrels
X
View Profile
View Bullboard History
Comment by
fourbarrels
on Dec 20, 2021 1:05am
RE:Dark pool activity?
DoJ Targets Anson Funds for Illegal Short-Selling, Fraud and Insider Trading – Market frauds Manipulation and fraud is rampant.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year